Sigyn Therapeutics, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

STOCK TRANSACTIONS (Details Narrative)

STOCK TRANSACTIONS (Details Narrative) - USD ($)							1 Months Ended						2 Months Ended	12 Months Ended
STOCK TRANSACTIONS (Details Narrative) - USD ($)	Dec. 31, 2018	Sep. 01, 2018	Jul. 08, 2018	Mar. 31, 2018	Jul. 14, 2017	Jun. 30, 2017	Nov. 30, 2018	Oct. 31, 2018	Jan. 31, 2018	Jan. 26, 2018	Mar. 17, 2017	Jan. 22, 2017	Feb. 28, 2018	Dec. 31, 2018	Dec. 31, 2017	May 19, 2017
Preferred stock cancellation term											10 years
Common stock payable															$ 79,625
Preferred stock value
Shares issued for services														$ 230,521	$ 755,884
CommonStock
Issuance of common stock and warrants with short-term convertible notes (in shares)														833,332	833,354
Shares issued for services														$ 547	$ 686
Shares issued for services (in shares)														5,468,750	6,861,768
Mr. Joseph Segelman [Member]
Preferred stock value																$ 270,000
Restricted Stock [Member]
Number of shares issued														4,750,000
Value of shares issued														$ 126,680
Stock issued for payment of accounts payable, Shares		5,000,000					8,000,000					150,000
Stock issued for payment of accounts payable, Value		$ 88,165					$ 117,600					$ 14,985
Issuance of common stock and warrants with short-term convertible notes (in shares)							2,500,000
Shares issued for services								$ 2,685							$ 755,884
Shares issued for services (in shares)								150,000							6,861,768
Restricted Stock [Member] \| Outside Consultant [Member]
Number of shares issued	162,500		100,000		487,500					568,750
Value of shares issued	$ 101,156		$ 2,390		$ 34,125
Common stock payable										$ 101,156
Contract terminated date					Jan. 26, 2018
Restricted Stock [Member] \| Employee [Member]
Number of shares issued															175,200
Value of shares issued															$ 16,920
Restricted Stock [Member] \| Advisor [Member]
Number of shares issued															200,000
Value of shares issued															$ 20,000
Restricted Stock [Member] \| Secured Promissory Note [Member] \| Alpha Capital Anstalt [Member]
Number of shares issued						1,500,000
Value of shares issued						$ 105,000
Crossover Capital Fund II, LLC \| Securities Purchase Agreement [Member]
Value of shares issued													$ 294,000
Crossover Capital Fund II, LLC \| CommonStock \| Securities Purchase Agreement [Member]
Number of shares issued													833,332
Crossover Capital Fund II, LLC \| Redeemable Shares \| Securities Purchase Agreement [Member]
Number of shares issued													3,000,000
Crossover Capital Fund II, LLC \| Warrants \| Securities Purchase Agreement [Member]
Number of shares issued													1,960,000
Value of shares issued													$ 250,000
Crossover Capital Fund II, LLC \| Restricted Stock [Member] \| Securities Purchase Agreement [Member]
Number of shares issued									2,395,650
Value of shares issued									$ 263,522
Brio Capital Master Fund Ltd. [Member] \| Secured Promissory Note [Member] \| Alpha Capital Anstalt [Member]
Principle amount						$ 1,125,000
Number of shares issued				600,000